GlaxoSmithKline plc (EGS38171C012)
EGX
Closed
Sep 3, 2026
Day's Range
314.0152 wk Range
55.10Profile - EGS38171C012 - GlaxoSmithKline plc
Profile
Mic Code
XCAI
Employees
0
GlaxoSmithKline plc is a global healthcare company that engages in the research and development, manufacturing, and marketing of pharmaceuticals, vaccines, and consumer healthcare products. Known for its innovative treatments in the areas of infectious diseases, oncology, and respiratory health, the company plays a crucial role in advancing healthcare solutions worldwide. GSK's diverse product portfolio includes well-known brands and life-saving medicines, impacting sectors such as pharmaceuticals and consumer health globally. With a focus on addressing urgent public health challenges, GlaxoSmithKline collaborates with governments, NGOs, and other industry players to enhance access to healthcare in both developed and emerging markets. The company’s significant research investment in vaccines and chronic condition treatments underscores its commitment to transforming the way diseases are managed, contributing substantially to global health advancements. Headquartered in London, GSK's influence is reflected in its presence across numerous international markets, making it a pivotal player in the life sciences industry.
Profile Details
Type
Common Stock
Country
Egypt
Cross Listings - EGS38171C012 - GlaxoSmithKline plc
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
